Literature DB >> 8607399

Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)

R B Singh1, M A Niaz, S S Rastogi, S Rastogi.   

Abstract

In a randomized, double-blind, placebo-controlled trial, the effects of combined treatment with the antioxidant vitamins A (50,000 IU/day), vitamin C (1,000 mg/day), vitamin E (400 mg/day), and beta-carotene (25 mg/day) were compared for 28 days in 63 (intervention group) and 62 (placebo group) patients with suspected acute myocardial infarction. After treatment with antioxidants, the mean infarct size (creatine kinase and creatine kinase-MB gram equivalents) was significantly less in the antioxidant group than in the placebo group. Serum glutamic-oxaloacetic transaminase decreased by 45.6 IU/dl in the antioxidant group versus 25.8 IU/dl in the placebo group (p < 0.02). Cardiac enzyme lactate dehydrogenase increased slightly (88.6 IU/dl) in the antioxidant group compared with that in the placebo group (166.5 IU/dl) (p < 0.01). QRS score in the electrocardiogram was significantly less in the antioxidant than in the placebo group. The following levels increased in the antioxidant group versus the placebo group, respectively: plasma levels of vitamin E increased by 8.8 and 2.2 mumol/L (p < 0.01), vitamin C increased by 12.6 and 4.2 mumol/L (p < 0.01), beta-carotene increased by 0.28 and 0.06 mumol/L (p < 0.01), and vitamin A increased by 0.36 and 0.12 mumol/L (p < 0.01). Serum lipid peroxides decreased by 1.22 pmol/ml in antioxidant versus 0.22 pmol/ml in the placebo group (p < 0.01). Angina pectoris, total arrhythmias, and poor left ventricular function occurred less often in the antioxidant group. Cardiac end points were significantly less in the antioxidant group (20.6% vs 30.6%, respectively). These results suggest that combined treatment with antioxidant vitamins A, E, C, and beta-carotene in patients with recent acute myocardial infarction may be protective against cardiac necrosis and oxidative stress, and could be beneficial in preventing complications and cardiac event rate in such patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607399     DOI: 10.1016/s0002-9149(97)89384-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  The role of oxidative stress in atherosclerosis: the hope and the hype.

Authors:  M S Runge
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

Review 2.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

Review 3.  Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.

Authors:  Paul G Shekelle; Sally C Morton; Lara K Jungvig; Jay Udani; Myles Spar; Wenli Tu; Marika J Suttorp; Ian Coulter; Sydne J Newberry; Mary Hardy
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

4.  Beta-carotene intake and risk of nonfatal acute myocardial infarction in women.

Authors:  A Tavani; E Negri; B D'Avanzo; C La Vecchia
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

5.  Pre-treatment with α-tocopherol and Terminalia arjuna ameliorates, pro-inflammatory cytokines, cardiac and apoptotic markers in myocardial infracted rats.

Authors:  Santosh K Shukla; Suman B Sharma; Usha R Singh
Journal:  Redox Rep       Date:  2014-09-02       Impact factor: 4.412

Review 6.  Antioxidants in health and disease.

Authors:  I S Young; J V Woodside
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

7.  Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction.

Authors:  N Khaper; K Kaur; T Li; F Farahmand; P K Singal
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

8.  Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione.

Authors:  Milton Hamblin; Holly M Smith; Michael F Hill
Journal:  J Card Fail       Date:  2007-12       Impact factor: 5.712

Review 9.  Antiatherogenic effects of vitamin E: the search for the Holy Grail.

Authors:  Dimitrios Kirmizis; Dimitrios Chatzidimitriou
Journal:  Vasc Health Risk Manag       Date:  2009-09-18

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.